31 May 2016
Kinase 2016: Next Generation Inhibitors took place at BioCity in Nottingham on Monday 16 - Tuesday 17 May 2016 and was a huge success.
The seventh SCI/RSC symposium on kinase inhibitor design featured several highly pertinent themes including new approaches and technologies to modulate and measure kinase function as well as diverse medicinal chemistry case studies. The symposium also drew on the lessons from history to provide insight into the future direction of the field.Available conference papers
- Kinase identification of proximal substrates (KIPS): a novel chemical genetics approach for kinase substrate identification, Dr Jon Roffey
- Fragment molecular orbital method in kinase ‘real-life’ structure-based drug design, Dr Ewa Chudyk
- Discovery and optimisation of 2,3-dihydroimidazo[1,2-c]quinazolines as PI3K inhibitors, Dr Julien LeFranc
- Identification of highly potent and mono-selective RIP1 kinase inhibitors targeting a unique allosteric pocket, Dr Phil Harris
- Design strategies for the development of selective kinase inhibitors, Dr Stefan Knapp